Cyclophosphamide Tablets IP

Next > >

<< Previous

Send Inquiry

Product Code : ON-I41

Price And Quantity

Product Specifications

Product Description

Cyclophosphamide Tablets IP

Indications :

Malignant Disease :

Malignant lymphomas (Stages III and IV of the Ann Arbor staging system).
Non-Malignant Disease : Biopsy proven minimal change nephrotic syndrome in children
Hodgkin's disease, lymphocytic lymphoma (nodular or diffuse), Mixed-cell type lymphoma.
Histiocytic lymphoma.
Burkitt's lymphoma.
Multiple myeloma.
Mycosis Fungoides

Dosage :
ADULTS AND CHILDREN :

General Oral Dosage : 400mg/m2 once daily for 5 days.

Dosage Adjustment :
Renal Impairment : Required
Hepatic Impairment : Not required

We are also dealing in:

Trade Information

Payment Terms
Telegraphic Transfer (T/T), Letter of Credit (L/C), Delivery Point (DP), Days after Acceptance (DA), Cash in Advance (CID), Cash Advance (CA), Cash on Delivery (COD)
Supply Ability
50000 Per Day

Sample Policy
Free samples are available
Main Export Market(s)
Africa, Middle East, Western Europe, Eastern Europe, South America, North America, Central America, Australia, Asia